marketing
Common sense approach to Internet marketing guidelines
It’s amazing that PhRMA would come up with recommended guidelines that seem to be developed over a cup of coffee rather than really think about how consumers use and need health information online. The people at PhRMA need to contact the sales people at Manhattan Research to get updated information before they pull ideas out of space.
Read the full storyeMarketing guidelines for health; A common sense approach
It’s amazing that PhRMA would come up with recommended guidelines that seem to be developed over a cup of coffee rather than really think about how consumers use and need health information online. The people at PhRMA need to contact the sales people at Manhattan Research to get updated information before they pull ideas out of space
Can Pharma Fill the HCP-to-Patient Social Media Vacuum?
In today’s #hcsmeu ( Healthcare Social Media in Europe ) discussion via Twitter, I posed the question ” Patient support via Twitter: is there a need for Pharma to do it? or should it be left to HCPs?” Actually, this was how Andrew Spong, a leader of the discussion, nicely rephrased it.
Read the full storyAt Last! Pharma eMarketing Comes of Age
I’ve actually heard of someone saying “2010 is going to be the year of digital,” and I kind of laughed inside my head a little. Wasn’t the breakout year of digital marketing a few years back?
Rozerem: Really bad marketing
You’ll never see any product from the drug industry make brand of the year for good reason; the marketing of prescription drugs is probably the worst marketing in the world. It’s not because the drug industry is a regulated industry it’s because the drug industry has become a factory that puts people in jobs to agree with others and check boxes rather than think about patients and how to interact with them.
Read the full storyIs it time to ditch tradional media for all DTC ?
Engaging
What Would A Pharma Marketing Champ Do? 9 Imperatives for 2010
This is the final post of a four-part series. Steve Jobs, Google, Good Life are three marketing champs. Read what Pharma marketing champs would do.
Read the full storyA focus on diseases for which it believes it can develop more valuable drugs
There is no doubt that developing new drugs is costlier and harder than ever before. There is a huge financial risk in developing drugs aimed at depression. Clinical trials of antidepressants are among the “most expensive and highest-risk” of all drug trials, Mr
Transparency Vs. Translucency in Reporting Physician Payments
“Transparency” is a word you often hear today. It’s being used a lot in relation to Wall Street bonuses. It’s also used by pharmaceutical companies who are reporting payments made to physicians.
New Regulatory Wrinkle: Cosmetic Doctor Gets FDA Warning Letter! Who Snitched?
In what has been called a “first,” the FDA “has cracked down on one of the most widely quoted cosmetic doctors, sending shudders through the ranks of opinion leaders in fashion publishing and vanity medicine,” according to the New York Times ( see here ). “The F.D.A. recently sent a warning letter to Dr










Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice